Citation Impact
Citing Papers
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.
1990
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits
1992
Pathophysiology of Progressive Nephropathies
1998 Standout
An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
2001
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Immunological responses to oxidized LDL
2000
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors
1995
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
2006
The metabolic syndrome
2010 Standout
Coronary heart disease attack rate, incidence and mortality 1975-1994 in Goteborg, Sweden
1997
Beyond Cholesterol
1989 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
Associations of low density lipoprotein particle composition with atherogenicity
2004
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Metabolic origins and clinical significance of LDL heterogeneity
2002
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.
1998
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects
2003
Psoriasis
2015 Standout
The metabolic syndrome
2005 Standout
Polycystic Ovary Syndrome
1995 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
1992
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
1996
Diabetes and Atherosclerosis
2002 Standout
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
2006
A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
1991
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
1998 Standout
Polycystic Ovary Syndrome
2005 Standout
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Phospholipase A2 Modification of Lipoproteins: Potential Effects on Atherogenesis
2002
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate
1991
Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis
1998
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
1992
What We Talk About When We Talk About Fat
2014 Standout
Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women
2006
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity
2011
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Atherosclerosis
2000 StandoutNature
Vitamin E Consumption and the Risk of Coronary Disease in Women
1993 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 Standout
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Atherosclerosis
2001 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Validation of the Framingham Coronary Heart Disease Prediction Scores
2001 Standout
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea
2005
Restricted Adipogenesis in Hypertrophic Obesity
2013
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Plasma triglyceride and coronary heart disease.
1991
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
1995
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study
2010
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
1992 Standout
Management of growth hormone deficiency in adults
2007
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
1987
Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression
1999
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
2001
Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells.
1994
Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.
1989
Platelet activation, upregulation of CD11b/CD18 expression on leukocytes and increase in circulating leukocyte-platelet aggregates in Indian women chronically exposed to biomass smoke
2006
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
2004
Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue.
1991
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis
2000
Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician
2000
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk
2006
The Response-to-Retention Hypothesis of Early Atherogenesis
1995
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
ACAT2 Is a Target for Treatment of Coronary Heart Disease Associated With Hypercholesterolemia
2005
Low density lipoprotein undergoes oxidative modification in vivo.
1989
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
The effect of alcohol on serum high density lipoprotein (HDL)
1983
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.
1992
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
Group V sPLA 2 Hydrolysis of Low-Density Lipoprotein Results in Spontaneous Particle Aggregation and Promotes Macrophage Foam Cell Formation
2004
Works of O. Wiklund being referenced
Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification.
1991
Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum
1989
Characteristics and Prognosis of Patients with Acute Myocardial Infarction in Relation to whether They Were Treated in the Coronary Care Unit or in Another Ward
1992
Increased Interleukin‐6 levels in pituitary‐deficient patients are independently related to their carotid intima‐media thickness
2003
Cholesterol: A Renal Risk Factor in Diabetic Nephropathy
1993
Computerized measurement of LDL particle size in human serum: Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis
1999
Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction
1989
Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes
2004
Serum triglycerides and HDL cholesterol — major predictors of long-term survival after coronary surgery
1994
LDL particle size in relation to intima‐media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia
2000
Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance
2004
Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system
1996
Ten‐year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia
2000
Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors Determination of apolipoprotein D
1980
Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors
1980
Alphalipoprotein cholesterol and arterial cholesterol in human uterine arteries.
1980
Serum lipids and apolipoprotein levels in women with acute myocardial infarction.
1988
A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin
2003
Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide.
1983
Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
1987